Patient: Page 12

  • A man walks out of the Pfizer world headquarters building.
    Image attribution tooltip
    Chris Hondros / Staff via Getty Images
    Image attribution tooltip
    Q&A

    Behind Pfizer's new quest to target a 'transformation' in pharma

    A combined venture with Roivant — called Priovant Therapeutics — is looking to be a forerunner in the burgeoning autoimmune disease market.

    By Kelly Bilodeau • July 25, 2022
  • newborn screening
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    The earlier the better: New consortium leverages infant screening to accelerate treatment

    Inozyme Pharma has joined a genomic sequencing program developing a novel rapid test for 388 genetic diseases.

    By Kim Ribbink • July 25, 2022
  • clinical trial diversity Explore the Trendline➔
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Trendline

    Clinical trial diversity

    As pharma wises up to the fact that the current playbook for improving clinical trial diversity has yet to make a meaningful impact, the quest is on to refine that approach.

    By PharmaVoice staff
  • A red Moderna sign hangs on the front of a beige building.
    Image attribution tooltip
    Maddie Meyer / Staff via Getty Images
    Image attribution tooltip

    Moderna's next vax target? A little-known cause of birth defects

    How the mRNA-based biotech is developing the first-ever prophylactic for a devastating virus.

    By Karissa Waddick • July 21, 2022
  • John LaMattina
    Image attribution tooltip

    Permission granted by John LaMattina

    Image attribution tooltip

    Pfizer's former R&D head takes on drug pricing misconceptions in new book

    John LaMattina has something to say about the industry — and he hopes patients are listening.

    By • July 19, 2022
  • science discovery and technological innovation
    Image attribution tooltip

    NanoStockk/istockphoto.com

    Image attribution tooltip
    Sponsored by OPEN Health

    How digital health is changing the relationship between patients and health providers

    The pandemic has forced the pharmaceutical industry to look at digital in a new way - and it’s driving better health outcomes

    July 18, 2022
  • Son holding father's hand at the hospital
    Image attribution tooltip
    FG Trade via Getty Images
    Image attribution tooltip
    Profile

    The power of the underdog: A rare disease nonprofit working to help patients win against the odds

    Elizabeth Izard Apelles is finding innovative ways to champion rare disease patients through an emerging platform from Honeycomb Health.

    By Alexandra Pecci • July 13, 2022
  • Geometric illustration of multi-colored human figures
    Image attribution tooltip
    iStock via Getty Images
    Image attribution tooltip

    Pharma companies take a fresh approach to inclusion in new DTC ads

    AstraZeneca and Amgen are emphasizing diversity and authenticity in campaigns for lupus and severe asthma therapies.

    By Karissa Waddick • July 5, 2022
  • Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    The oncology market is surging despite a decline in routine screenings

    A new report from IQVIA reveals the current challenges — and promise — in cancer drug R&D.

    By Kelly Bilodeau • June 28, 2022
  • Oral contraceptive pill on pharmacy counter with colorful pills strips background.
    Image attribution tooltip
    iStock via Getty Images
    Image attribution tooltip

    With abortion access restricted across the U.S., a new diagnostic aims to eliminate birth control's pain points

    The hormonal and genetic test developed by Adyn is designed to predict and prevent adverse birth control side effects.

    By Karissa Waddick • June 28, 2022
  • Image attribution tooltip

    Permission granted by Dan Vahdat.

    Image attribution tooltip
    Q&A

    'Nobel Prize of pharma' helps put Huma's digital health platform on the global map

    The company’s CEO explains how its Prix Galien award-winning app bridges patient care, treatment support and clinical research.

    By Kim Ribbink • June 23, 2022
  • Image attribution tooltip
    Karissa Waddick/PharmaVoice
    Image attribution tooltip

    #DIA2022: Building 'guardrails' in the FDA's accelerated approval program

    Regulatory experts weigh in on ways to enhance the controversial drug approval approach.

    By Karissa Waddick • June 21, 2022
  • A person in a white doctors coat and stethoscope holds up a magnifying glass.
    Image attribution tooltip
    Valiantsin Suprunovich via Getty Images
    Image attribution tooltip

    The public health sleuth

    In her decades-long career, Mary Pittman, CEO of the Public Health Institute, has seen — and helped solve — one public health mystery after another.

    By Alexandra Pecci • June 21, 2022
  • schizophrenia
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Q&A // Biotech Spotlight

    Biotech spotlight: Karuna Therapeutics’ mission to rejuvenate the field of neuroscience

    An effective treatment for psychiatric disorders such as schizophrenia might require a holistic approach to avoid serious side effects, says CEO Steve Paul.

    By Kim Ribbink • June 16, 2022
  • Boy in wheelchair
    Image attribution tooltip
    ChiccoDodiFC via Getty Images
    Image attribution tooltip

    A patient-funded ALS drug offers hope where few treatments exist

    Eledon Pharmaceuticals’ grassroots-backed drug recently entered clinical trials.

    By Kelly Bilodeau • June 15, 2022
  • brain drug
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Q&A

    A combo of precision meds and diagnostics could disrupt mental healthcare

    HMNC Brain Health, a clinical-stage company, is leveraging cutting-edge tech to offer a new approach to mental health challenges.

    By Kelly Bilodeau • June 8, 2022
  • drug development
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Profile

    After losing her daughter to a rare disease, Sharon King is looking to rewrite the playbook of drug development

    The communications pro is lending her community-building, storytelling expertise to the Bespoke Gene Therapy Consortium.

    By Alexandra Pecci • June 7, 2022
  • The sun rises over the rural, Tennessee mountain town of Gatlinburg.
    Image attribution tooltip
    Jonathan Ross via Getty Images
    Image attribution tooltip

    Pharma giants take on Appalachian cancer rates in newest screening initiative

    AstraZeneca and Bristol Myers Squibb are teaming up with the nonprofit Association of Community Cancer Centers to increase lung cancer screening in rural Appalachia for the long haul.

    By Karissa Waddick • June 7, 2022
  • Medicare enrollment form and money.
    Image attribution tooltip
    iStock via Getty Images
    Image attribution tooltip

    Aduhelm's Medicare woes leave questions about lofty premiums

    A single drug’s effect on the premiums that Medicare beneficiaries pay is raising questions about how these levels are set and what factors play a part.

    By Kelly Bilodeau • June 2, 2022
  • Close-up Of A Businesswoman Hand Stopping Colorful Dominoes From Falling On Office Desk
    Image attribution tooltip
    AndreyPopov via Getty Images
    Image attribution tooltip

    Pharmas can be 'more than medicine' by focusing on preventative care

    Why pharma companies are changing their tack to become more than the products they sell.

    By • May 24, 2022
  • Digital background depicting innovative technologies in (AI) artificial systems, neural interfaces and internet machine learning technologies
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Q&A

    The UK-based company that's striving to overcome the limitations of T cell receptor innovation

    Etcembly’s CEO, Michelle Teng, shares why a platform approach to T cell receptors can advance and democratize innovation.

    By Kim Ribbink • May 23, 2022
  • medical communications
    Image attribution tooltip
    sturti via Getty Images
    Image attribution tooltip
    Sponsored by ClinicalMind

    3 things medical communications can learn from sales training experts

    Medical communications is moving toward more modern approaches that can make critical information more engaging and better able to "stick".

    May 23, 2022
  • Image attribution tooltip
    John Moore via Getty Images
    Image attribution tooltip

    A potential COVID-19 EUA could turn this small biotech into a household name

    Veru’s CEO discusses the impact of the upcoming FDA decision on its treatment targeting severely ill COVID-19 patients.

    By • May 19, 2022
  • SpringWorks Therapeutics chief medical officer Jim Cassidy
    Image attribution tooltip
    Permission granted by SpringWorks/Jim Cassidy
    Image attribution tooltip
    Profile

    Jumping into pharma with big plans at a small company

    SpringWorks Therapeutics' chief medical officer on the ambition that drives him and his company to develop treatments for cancer patients.

    By Alexandra Pecci • May 17, 2022
  • Image attribution tooltip
    Spencer Platt via Getty Images
    Image attribution tooltip
    Q&A

    BriOri BioTech sets the stage for the comeback of Vioxx

    With a topical pain-relieving ointment in development, the emerging biotech is aiming to give the tarnished NSAID a new life.

    By Kelly Bilodeau • May 17, 2022
  • Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    Are digital DCTs the answer for rare diseases?

    How data from EHRs is helping to identify, diagnose and recruit patients to decentralized clinical trials.

    By Kim Ribbink • May 16, 2022